Medicines Formulary

Medicines A–Z

P

Drug name	NICE TAs	Comments
Pancuronium injection
Panitumumab concentrate for infusion	TA439 - Cetuximab and panitumumab for previously untreated metastatic colorectal cancer TA242 - Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy	Negative TA
Panobinostat	TA380 - Panobinostat for treating multiple myeloma after at least 2 previous treatments
Paracetamol 1000mg/100ml infusion
Paracetamol SF suspension
Paracetamol soluble tablets		High sodium content - only if swallowing difficulties.
Paracetamol suppositories
Paracetamol tablets
Paraffin yellow soft BP		CCU/ITU use
Paraldehyde rectal solution 50% in olive oil (10ml)

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.